ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 474,59
0,69%
Dow Jones
43 221,55
1,65%
DAX
20 574,68
1,55%
Brent Oil
81,68
2,48%
Bitcoin
99 669,76
3,28%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Heron Therapeautics Inc (HRTX) Cours

Heron Therapeautics Inc

Heron Therapeautics Inc (HRTX)

NASDAQ
1,52
0,05
(3,40%)
À la fermeture: 16 Janvier 10:00PM
Retardé de 15 minutes
1,50
-0,02
( -1,32% )
Après les heures de négociation: 11:00PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
1,50
Prix Achat
1,50
Prix Vente
1,55
Volume échangé
809 148
1,48 Fourchette du Jour 1,54
1,04 Plage de 52 semaines 3,93
Cap du marché
228,142M
Clôture Veille
1,47
Ouverture
1,50
Dernière Transaction
6
@
1.5007
Dernière heure de transaction
23:27:49
Volume financier
US$ 1 226 591
VWAP
1,5159
Volume moyen (3 m)
3 329 048
Actions en circulation
152 094 912
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,09
Bénéfice par action (BPA)
-0,73
Chiffre d'affairess
127,04M
Bénéfice net
-110,56M

À propos de Heron Therapeautics Inc

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011. Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.herontx.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Heron Therapeautics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker HRTX. Le dernier cours de clôture d'Heron Therapeautics était de US$1,47. Au cours de la dernière année, les actions de Heron Therapeautics ont été négociées dans une fourchette de prix de US$ 1,04 à US$ 3,93.

Heron Therapeautics compte actuellement 152 094 912 actions en circulation. La capitalisation boursière d'Heron Therapeautics est de US$223,58 million. Heron Therapeautics a un ratio cours/bénéfice (ratio PE) de -2.09.

HRTX Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

23 Décembre 2024
Edgar (US Regulatory)

Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina

Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina PR Newswire SAN DIEGO, Dec. 23, 2024 SAN DIEGO, Dec. 23, 2024 /PRNewswire/ -- Heron Therapeutics, Inc...

23 Décembre 2024
PR Newswire (US)

Form 8-K - Current report

03 Décembre 2024
Edgar (US Regulatory)

U.S. District Court Upholds Validity of CINVANTI® Patents

U.S. District Court Upholds Validity of CINVANTI® Patents PR Newswire SAN DIEGO, Dec. 3, 2024 — Court Rules in Favor of Heron in Patent Lawsuit Against Fresenius Kabi USA, LLC — SAN DIEGO, Dec...

03 Décembre 2024
PR Newswire (US)

Form 8-K - Current report

12 Novembre 2024
Edgar (US Regulatory)

Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance

Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance PR Newswire SAN DIEGO, Nov. 12, 2024 Reported positive YTD 2024 Adjusted EBITDA of $1.4...

12 Novembre 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

06 Novembre 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

05 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

04 Novembre 2024
Edgar (US Regulatory)

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors PR Newswire SAN DIEGO, Nov. 4, 2024 SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq:...

04 Novembre 2024
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.18-10.71428571431.681.691.4610960221.53485259CS
4-0.15-9.090909090911.651.831.4617054751.59273817CS
12-0.28-15.73033707871.781.9951.0433290481.55312737CS
26-1.79-54.40729483283.293.731.0426400391.83926669CS
52-0.65-30.23255813952.153.931.0425664452.31938336CS
156-6.98-82.31132075478.489.450.525733932.76616425CS
260-21.12-93.368700265322.6225.030.520662495.827232CS

HRTX - Frequently Asked Questions (FAQ)

What is the current Heron Therapeautics share price?
The current share price of Heron Therapeautics is US$ 1,50
How many Heron Therapeautics shares are in issue?
Heron Therapeautics has 152 094 912 shares in issue
What is the market cap of Heron Therapeautics?
The market capitalisation of Heron Therapeautics is USD 223,58M
What is the 1 year trading range for Heron Therapeautics share price?
Heron Therapeautics has traded in the range of US$ 1,04 to US$ 3,93 during the past year
What is the PE ratio of Heron Therapeautics?
The price to earnings ratio of Heron Therapeautics is -2,09
What is the cash to sales ratio of Heron Therapeautics?
The cash to sales ratio of Heron Therapeautics is 1,82
What is the reporting currency for Heron Therapeautics?
Heron Therapeautics reports financial results in USD
What is the latest annual turnover for Heron Therapeautics?
The latest annual turnover of Heron Therapeautics is USD 127,04M
What is the latest annual profit for Heron Therapeautics?
The latest annual profit of Heron Therapeautics is USD -110,56M
What is the registered address of Heron Therapeautics?
The registered address for Heron Therapeautics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Heron Therapeautics website address?
The website address for Heron Therapeautics is www.herontx.com
Which industry sector does Heron Therapeautics operate in?
Heron Therapeautics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
PMAXPowell Max Ltd
US$ 2,40
(73,80%)
4,73M
SLXNSilexion Therapeutics Corporation
US$ 2,61
(67,31%)
7,5M
NEHCNew Era Helium Inc
US$ 3,6094
(20,31%)
7,93k
LTRYLottery com Inc
US$ 0,4611
(18,53%)
302,04k
SOBRSOBR Safe Inc
US$ 1,05
(17,98%)
2M
TOIIWOncology Institute Inc
US$ 0,0117
(-26,42%)
1,12k
SVMHSRIVARU Holding Ltd
US$ 0,7399
(-19,25%)
1,24M
RIMEAlgorhythm Holdings Inc
US$ 0,0419
(-16,53%)
19,13M
LUXHLuxUrban Hotels Inc
US$ 0,59
(-14,26%)
233,35k
AMIXAutonomix Medical Inc
US$ 2,65
(-12,83%)
212,91k
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,26995
(16,21%)
27,41M
RIMEAlgorhythm Holdings Inc
US$ 0,0419
(-16,53%)
19,13M
ACONAclarion Inc
US$ 0,0446
(4,94%)
8,84M
SLXNSilexion Therapeutics Corporation
US$ 2,61
(67,31%)
7,5M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,065
(0,62%)
4,9M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
HRTX
Heron Therapeautics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés